Crislip v. TCH Liquidating Co.

556 N.E.2d 1177, 52 Ohio St. 3d 251, 1990 Ohio LEXIS 298
CourtOhio Supreme Court
DecidedJuly 18, 1990
DocketNo. 89-447
StatusPublished
Cited by78 cases

This text of 556 N.E.2d 1177 (Crislip v. TCH Liquidating Co.) is published on Counsel Stack Legal Research, covering Ohio Supreme Court primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Crislip v. TCH Liquidating Co., 556 N.E.2d 1177, 52 Ohio St. 3d 251, 1990 Ohio LEXIS 298 (Ohio 1990).

Opinion

Wright, J.

The Crislips, plaintiffs-appellees, do not allege a design or manufacturing defect in the Timber Iron Furnace Caddy. Rather, they claim that the failure of defendant-appellant, TCH Liquidating Company, to adequately warn them of the danger of carbon monoxide poisoning rendered the Timber Iron unreasonably dangerous. This court has adopted Section 402A of 2 Restatement of the Law 2d, Torts (1965) 347, along with Comment j, at 353, which allows a cause of action in strict liability when failure to warn renders a product unreasonably dangerous. Thus, we agree with the court of appeals that the trial court committed error in directing a verdict for defendants on the strict liability cause of action. An individual injured by a known dangerous product may prosecute a strict liability claim arising from allegations of inadequate warning. However, because the trial court’s refusal to let the jury decide the strict liability question was harmless error under the facts of this case, we reverse the court of appeals’ decision that the directed verdict be reversed and the cause remanded for trial on the strict liability claim, and we reinstate the judgment of the trial court.

Strict liability for defective products in Ohio follows the formulation in Section 402A of the Restatement, supra. Temple v. Wean United, Inc. (1977), 50 Ohio St. 2d 317, 4 O.O. 3d 466, 364 N.E. 2d 267, paragraphs one and two of the syllabus. Section 402A provides as follows:

“Special Liability of Seller of Product for Physical Harm to User or Consumer

“(1) One who sells any product in a defective condition unreasonably dangerous to the user or consumer or to his property is subject to liability for physical harm thereby caused to the ultimate user or consumer, or to his property, if

“(a) the seller is engaged in the business of selling such a product, and

“(b) it is expected to and does reach the user or consumer without substantial change in the condition in which it is sold.

‘ ‘(2) The rule stated in Subsection (1) applies although

“(a) the seller has exercised all possible care in the preparation and sale of his product, and

“(b) the user or consumer has not bought the product from or entered into any contractual relation with the seller.”

One of the reasons given in Temple for approving Section 402A was that “* * * the Restatement formulation, together with its numerous illustrative comments, greatly facilitates analysis in this area * * *.” Id. at 322, 4 O.O. 3d at 469, 364 N.E. 2d at 271. Comment j pertains to failure to warn, and provides in pertinent part:

“Directions or warning. In order [255]*255to prevent the product from being unreasonably dangerous, the seller may be required to give directions or warning, on the container, as to its use. The seller may reasonably assume that those with common allergies, as for example to eggs or strawberries, will be aware of them, and he is not required to warn against them. Where, however, the product contains an ingredient to which a substantial number of the population are allergic, and the ingredient is one whose danger is not generally known, or if known is one which the consumer would reasonably not expect to find in the product, the seller is required to give warning against it, if he has knowledge, or by the application of reasonable, developed human skill and foresight should have knowledge, of the presence of the ingredient and the danger. Likewise in the case of poisonous drugs, or those unduly dangerous for other reasons, warning as to use may be required.

“* * *

“Where warning is given, the seller may reasonably assume that it will be read and heeded; and a product bearing such a warning, which is safe for use if it is followed, is not in defective condition, nor is it unreasonably dangerous.”

Thus, a product may be unreasonably dangerous and strict liability may apply as the result of the lack of an adequate warning even though the product has no design or manufacturing defect. This is just what the plaintiffs here alleged, but the trial court granted defendants’ directed verdict motion, erroneously stating that Ohio does not recognize an action in strict liability for failure to warn.

Appellant TCH argues that in Temple, supra, this court ruled that a cause of action for failure to warn sounds in negligence but not in strict liability, quoting the following sentence from that case: “It is, however, apparent that the rule imposing obligation on the manufacturer or seller to give suitable warning of a dangerous propensity of a product is a rule fixing a standard of care, and any tort resulting from the failure to meet this duty is, in essence, a negligent act. * * *” Temple, supra, at 325, 4 O.O. 3d at 470-471, 364 N.E. 2d at 272-273. Taken out of context, this statement seems to limit a plaintiff alleging failure to warn to an action in negligence and to prohibit such a plaintiff from bringing the action in strict liability.

Understood in its context, however, the quoted statement does not disallow a strict liability action for failure to give an adequate warning. The plaintiffs in Temple, like the Crislips, argued only that the product which caused injury “* * * was defective in that it was unreasonably dangerous and was placed in the hands of the user, Mrs. Temple, without adequate warning. * * *” Id. at 321, 4 O.O. 3d at 468, 364 N.E. 2d at 270. We noted in the next sentence that this cause of action was premised on Comment j, then quoted from Comment j, and concluded the paragraph by approving Section 402A. Id. at 321-322, 4 O.O. 3d at 468-469, 364 N.E. 2d at 270-271. Nowhere in Temple did we disapprove of, or refuse to adopt, Comment j.

We did not address the applicability of Commenty to the facts of Temple because the plaintiffs’ strict liability claim failed on two other grounds: two defendants were absolved because the product had undergone a substantial change after leaving their hands, thus falling outside the scope of Section 402A (see 402A[1][b]); and the other defendant had manufactured a component part, but had not overseen its in[256]*256tegration into the machine, which this court found not to give rise to strict liability. Id. at 323-325, 4 O.O. 3d at 469-470, 364 N.E. 2d at 271-272.

The plaintiffs were precluded from pressing their strict liability claim in Temple not because they alleged a cause of action that we categorically refuse to recognize but. because of other factors peculiar to their case. Having explained why the strict liability claim had to fail, we then observed that another tort theory was available to the plaintiffs: negligent failure to warn. Thus, when we wrote that the failure to meet the duty to warn “* * * is a rule fixing a standard of care, and any tort resulting from the failure to meet this duty is, in essence, a negligent act * * *,” we did not mean that negligence is the exclusive cause of action for failure to warn, but rather that a negligence action is an alternative to a strict liability cause of action for failure to warn. Plaintiffs may plead both negligence and strict liability for failure to warn.

TCH also urges us to accept the distinction, proposed in Krosky, supra, between failure to provide any warning at all and failure to provide an adequate warning. Although Krosky

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Sidloski v. Fischer
2025 Ohio 5069 (Ohio Court of Appeals, 2025)
Linert v. Foutz (Slip Opinion)
2016 Ohio 8445 (Ohio Supreme Court, 2016)
Albright v. Boston Scientific Corp.
58 N.E.3d 360 (Massachusetts Appeals Court, 2016)
Rheinfrank v. Abbott Laboratories, Inc.
119 F. Supp. 3d 749 (S.D. Ohio, 2015)
Linda Buck v. Ford Motor Company
526 F. App'x 603 (Sixth Circuit, 2013)
Lawrence Ex Rel. B.J. v. Raymond Corp.
501 F. App'x 515 (Sixth Circuit, 2012)
Doane v. Givaudan Flavors Corp.
2009 Ohio 4989 (Ohio Court of Appeals, 2009)
Boyd v. Lincoln Electric Co.
902 N.E.2d 1023 (Ohio Court of Appeals, 2008)
Ronske v. the Heil Co., 2006-Ca-00168 (10-9-2007)
2007 Ohio 5417 (Ohio Court of Appeals, 2007)
Reece v. Astrazeneca Pharmaceuticals, LP
500 F. Supp. 2d 736 (S.D. Ohio, 2007)
Aldridge v. Reckart Equip. Co., Unpublished Decision (9-19-2006)
2006 Ohio 4964 (Ohio Court of Appeals, 2006)
Woeste v. Washington Platform Saloon & Restaurant
836 N.E.2d 52 (Ohio Court of Appeals, 2005)
State Farm Mutual Automobile Insurance v. Kia Motors America, Inc.
828 N.E.2d 701 (Ohio Court of Appeals, 2005)
Jordan v. Dayton Testing Lab, Unpublished Decision (5-14-2004)
2004 Ohio 2425 (Ohio Court of Appeals, 2004)

Cite This Page — Counsel Stack

Bluebook (online)
556 N.E.2d 1177, 52 Ohio St. 3d 251, 1990 Ohio LEXIS 298, Counsel Stack Legal Research, https://law.counselstack.com/opinion/crislip-v-tch-liquidating-co-ohio-1990.